Archive →
Daily Morning Briefing

Friday, 15 May 2026

Trump–Xi summit day two — tea at Zhongnanhai, China urges Hormuz reopening · Powell's term ends, Warsh sworn in · inflation angst lifts global yields · Cerebras jumps 68% on debut · Burnham moves on Starmer
Europe/Rome 06:00 · Wall St closed at records Thu · Asia softer · yields climb on inflation · US Empire mfg 14:30 · industrial production 15:15 · U-Mich prelim 16:00 CET

Top of the morning

Markets snapshot — live levels at the Rome open

Levels read this morning from Bloomberg's live Europe homepage ticker via Control Chrome. US cash equity values reflect Thursday's record close carried into pre-open; crude and gold are intra-session; Asia values are the most recent prints available from cross-referenced reporting and are labelled as such.

InstrumentLastChange / context
S&P 5007,501.24+0.77% · Thu record close
Nasdaq Composite26,635.22+0.88% · Thu record, tech-led
BBG B5002,706.17+0.79%
US 10y Treasury4.52%yields leading higher on inflation angst
Crude (WTI front-month)$102.46+1.28% · weekly advance, Gulf of Oman attack
FTSE 10010,372.93+0.46% · gilts soft on Burnham challenge
Gold (XAU spot)$4,619.20+1.41% on the day · still set for a weekly drop
EUR/USD1.17+0.15% · dollar broadly steady
GBP/USD1.34+0.21% · sterling carries UK political discount
Nikkei 225~−0.9% this morning · Japan PPI hottest since 2014
Kospi~−1.3% · slips from record, global funds exiting
Hang Seng~−0.4% · Trump–Xi the swing factor

Geopolitics & today's watch

Beijing remains the centre of gravity, and day two moved the venue from formal halls into Zhongnanhai itself — a deliberate intimacy signal. The deliverables that have surfaced are economic: a willingness on both sides to extend the trade truce, an expectation of large Chinese agricultural purchases, and Trump's claim that Xi is warm to buying more US oil. The most macro-relevant line is Beijing publicly urging a reopening of the Strait of Hormuz and Trump saying China offered help on Iran — if that translates into Chinese pressure on Tehran, it is the first plausible diplomatic off-ramp for the oil shock in twelve weeks. Hold the structural caveat: Xi has the leverage, the harder files (Taiwan, rare earths, any signal on Iranian crude) may stay unresolved, and the summit's close today is the binary moment.

The Iran file is still the operational pivot underneath everything. A ship was attacked and sunk in the Gulf of Oman near the UAE overnight, India condemned it, and crude pushed back above $102 with oil set for a weekly gain. The Washington politics are fracturing — a GOP-led House tied on halting the Iran war as opposition mounts, the clearest erosion of congressional support yet — while Trump downplayed the uranium issue as mostly "public relations." India hiking domestic fuel prices for the first time in four years is the inflation pass-through becoming concrete in a major economy, and ECB official Stournaras's warning that high oil could force a rate hike shows the shock is now feeding directly into the European policy debate.

Two adjacent threads. First, the UK: the Burnham route to challenge Starmer makes British politics the cleanest live event in the European session, with sterling and gilts carrying the discount and no domestic data today to settle the question either way. Second, Russia/Ukraine: Bloomberg reports Russia is pressing college students to fill the ranks of drone pilots — a manpower-strain signal worth tracking as the war grinds on, and a reminder that the conflict's trajectory remains a slow-burn risk for European energy and defence even with Iran dominating the headlines.

Central banks & the rate-cut narrative

The US story is now a transition story in real time. Powell's term as chair ends today, Warsh is sworn in, and Miran steps down as a governor on the same day — a clustered handover landing into a bond market already repricing. Treasuries are leading global yields higher on inflation angst with the 10-year at 4.52%, gold is set for a weekly drop as faster inflation fuels rate-hike bets, and Fed officials remain audibly split, with Barr calling balance-sheet shrinkage the "wrong objective." The practical read for the curve is unchanged from earlier in the week: a front end still theoretically open to cuts against a long end carrying a credibility-and-fiscal premium, with the steepening bias the cleaner expression than any single directional call. Today's US data — Empire State manufacturing, industrial production and the preliminary U-Mich sentiment and inflation-expectations read — are the first numbers the Warsh-era narrative gets measured against.

Outside the US, the picture is one of inflation pressure building rather than easing. Japan's producer prices jumped the most since 2014, hardening the BOJ-hike case; Romania's central bank is set to hold with explicit stagflation risks flagged; and the ECB debate now openly includes oil-driven upside scenarios after Stournaras's hawkish warning. The through-line across regions is that the disinflation narrative that underpinned the soft-landing trade is under visible strain — the FT's "disinflation disappears" framing, sitting open in Luca's tabs, captures the mood. There is no major European central-bank decision today; the next set-pieces are the ECB and BOJ in June and the first Fed meeting under the new chair on 16–17 June.

Big Tech, AI & corporates

The AI capital story keeps widening rather than consolidating. Cerebras jumped 68% on debut in the year's biggest IPO, minting a $3.2bn fortune for its CEO and billions in returns for Benchmark and Eclipse; OpenAI's CFO says it may need to raise more as the compute crunch deepens; Alphabet sold the largest-ever yen bond by a foreign issuer to fund the buildout; and JPMorgan lifted its Taiex bull case to 50,000 on the hardware cycle. But the breadth tells matter as much as the headline momentum — global funds are accelerating out of Korea even as its rally extends, and an Anthropic dispute with the US government is now a named risk factor for Figma and peers. The legal overhang around the sector's origins is also live: the Apple–OpenAI alliance is fraying toward a possible court fight, and Musk and Altman delivered their closing pitches to the jury in the OpenAI control trial.

Around the deal and corporate tape: LVMH agreed to sell Marc Jacobs to WHP Global; Elliott struck a board settlement at Dexcom after building a stake; Honda and Nissan's diverging fortunes have revived merger speculation; Kushner's Thrive Capital invested $100m in Shopify; and Gautam Adani's $18m SEC settlement moves a multi-year legal overhang toward resolution. Germany weighing roughly €3bn in subsidy cuts is the European fiscal-strain note threaded through the corporate news. The composition picture for Luca's equity exposure is unchanged: a market still rewarding AI-infrastructure scarcity and defence, with the risk concentrated in how much of the soft-landing assumption survives a genuine re-acceleration in inflation.

Health & science (worth a glance)

The hantavirus story stayed in the reassurance lane overnight — Bloomberg reports no further US cases, and nothing in the reporting changes the clinical picture: high case fatality in severe hantavirus pulmonary syndrome, but very low person-to-person transmissibility, which keeps this a surveillance-and-rodent-exposure story rather than a pandemic mechanism. The durable lesson from the week's coverage remains the funding fragility of vaccine and antiviral pipelines, not the pathogen itself.

On US health policy, the Supreme Court has — for now — preserved access to the abortion pill by mail. It is a procedural hold rather than a final merits ruling, but it keeps the current telehealth-prescribing and mail-dispensing pathway intact in the near term, useful context for anyone tracking how US clinical practice and pharmacy regulation are evolving under the current administration. And on the lifestyle-medicine front, Bloomberg's feature on midlife men facing pressure to extend their "hotspan" is the cultural mirror of the longevity conversation — a reminder of how quickly healthspan science gets repackaged as consumer wellness marketing, which is itself worth a clinician's skeptical eye.

Week ahead (CET)